Ibogaine Research Database

692 research records indexed from PubMed. Plain-language summaries where available.

Of these, 52 are human clinical studies (trials, observational studies, or case reports), 398 are preclinical (animal or lab) studies, and 112 are reviews or meta-analyses summarizing other researchers’ data. A record appearing here does not by itself mean ibogaine is proven effective for a given condition — see each condition page’s evidence breakdown for what’s actually established.

Compare evidence by condition →

All Studies (692)Depression (56)PTSD (24)Alcohol Addiction (20)Heroin Addiction (16)Opioid Addiction (15)Cocaine Addiction (15)Anxiety (13)Methamphetamine Addiction (12)Traumatic Brain Injury (2)

All Studies(692 of 692)

Distribution of ibogaine and noribogaine in a man following a poisoning involving root bark of the Tabernanthe iboga shrub.

Kontrimaviciūte, Mathieu, Mathieu-Daudé et al.· J Anal Toxicol· 2006· PMID: 16959135
Case Report

In the present paper, we report for the first time the tissue distribution of ibogaine and noribogaine, the main metabolite of ibogaine, in a 48-year-old Caucasian male, with a history of drug abuse, found dead at his home after a poisoning involving the ingestion of root bark fr...

Liquid chromatography-electrospray mass spectrometry determination of ibogaine and noribogaine in human plasma and whole blood. Application to a poisoning involving Tabernanthe iboga root.

Kontrimaviciūte, Breton, Mathieu et al.· J Chromatogr B Analyt Technol Biomed Life Sci· 2006· PMID: 16798116
Unclassified

A liquid chromatography/electrospray ionization mass spectrometry (LC-ESI-MS) method was developed for the first time for the determination of ibogaine and noribogaine in human plasma and whole blood. The method involved solid phase extraction of the compounds and the internal st...

Ibogaine may help drug addicts live the 'never again'.

Bateman· S Afr Med J· 2006· PMID: 16909175
Unclassified

Ibogaine affects brain energy metabolism.

Paskulin, Jamnik, Zivin et al.· Eur J Pharmacol· 2006· PMID: 17054944
Preclinical (Animal)

Ibogaine is an indole alkaloid present in the root of the plant Tabernanthe iboga. It is known to attenuate abstinence syndrome in animal models of drug addiction. Since the anti-addiction effect lasts longer than the presence of ibogaine in the body, some profound metabolic chan...

Complementary medicines in psychiatry: review of effectiveness and safety.

Werneke, Turner, Priebe· The British journal of psychiatry : the journal of mental science· 2006· PMID: 16449696
Review

The use of complementary medicines in those with mental health problems is well documented. However, their effectiveness is often not established and they may be less harmless than commonly assumed. To review the complementary medicines routinely encountered in psychiatric practi...

sigma Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons.

Zhang, Cuevas· J Pharmacol Exp Ther· 2005· PMID: 15764734
Preclinical (Animal)

The sigma receptors have been implicated in the regulation of the cardiovascular system, and sigma-1 receptor transcripts have been found in parasympathetic intracardiac neurons. However, the cellular function of sigma-1 receptors in these cells remains to be determined. Effects ...

Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme.

Andrade, Lima, Pinto et al.· Bioorg Med Chem· 2005· PMID: 15911323
Preclinical (Animal)

Ten indole alkaloids from the chloroform extract of stalk of Tabernaemontana australis (Muell. Arg) Miers were tentatively identified by GC-MS, viz., coronaridine (1), voacangine (2), voacangine hydroxyindolenine (3), rupicoline (4), ibogamine (5), ibogaine (6), ibogaline (7), de...

Nicotinic agonists, antagonists, and modulators from natural sources.

Daly· Cell Mol Neurobiol· 2005· PMID: 16075378
Review

1. Acetylcholine receptors were initially defined as nicotinic or muscarinic, based on selective activation by two natural products, nicotine and muscarine. Several further nicotinic agonists have been discovered from natural sources, including cytisine, anatoxin, ferruginine, an...

Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.

Meschini, Marra, Condello et al.· Int J Oncol· 2005· PMID: 16273216
Unclassified

Multidrug resistance (MDR) in tumor cells is generally associated with increased efflux of the cytotoxic compounds, due to the activation of mechanisms of intracellular transport and to the overexpression of surface proteins, such as P-glycoprotein (Pgp), which act as ATP-depende...

Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.

Panchal, Taraschenko, Maisonneuve et al.· Eur J Pharmacol· 2005· PMID: 16289028
Preclinical (Animal)

18-Methoxyroconaridine (18-MC), a synthetic derivative of ibogaine, reduces morphine self-administration and alleviates several signs of acute opioid withdrawal in rats. Although there is already well documented evidence of the mechanism mediating 18-MC's action to reduce the rew...

Quantitation of ibogaine and 12-hydroxyibogamine in human plasma by liquid chromatography with fluorimetric detection.

Kontrimaviciūte, Larroque, Briedis et al.· J Chromatogr B Analyt Technol Biomed Life Sci· 2005· PMID: 16002351
Unclassified

A high-performance liquid chromatographic (HPLC) method with fluorimetric detection was developed for the simultaneous determination of ibogaine and noribogaine in human plasma using fluorescein as internal standard. This method involved a solid phase extraction of the compounds ...

Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.

Vastag· Science· 2005· PMID: 15831735
Preclinical (Animal)

Natural medicines for alcoholism treatment: a review.

Xu, Zheng, Sung· Drug Alcohol Rev· 2005· PMID: 16361209
Review

Alcoholism is a serious problem throughout the world. The development of alcoholism remedies have medical, social and economical significance. In view of the pitfalls of psychological dependence and adverse behavioural effects of synthetic drugs, the development of low toxicity a...

Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption.

He, McGough, Ravindranathan et al.· J Neurosci· 2005· PMID: 15659598
Preclinical (Animal)

Alcohol addiction manifests as uncontrolled drinking despite negative consequences. Few medications are available to treat the disorder. Anecdotal reports suggest that ibogaine, a natural alkaloid, reverses behaviors associated with addiction including alcoholism; however, becaus...

Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections.

Yordanov, Dimitrova, Patkar et al.· J Med Microbiol· 2005· PMID: 15947429
Preclinical (Animal)

In the present study the effect of the indole alkaloid ibogaine on the in vitro lipolytic activity and adherence to epithelial cells of Candida albicans was investigated. The substance was administered intraperitoneally at a dose of 5 mg kg(-1) day(-1) in mice with disseminated a...

GDNF and addiction.

Ron, Janak· Rev Neurosci· 2005· PMID: 16519005
Review

Biochemical adaptations to drugs of abuse and alcohol are especially profound in midbrain dopaminergic neurons. Long-lasting molecular and structural changes in mesolimbic dopaminergic neurons that result from chronic exposure to drugs of abuse and alcohol are thought to underlie...

Cytotoxic effects and reversal of multidrug resistance by ibogan and related indole alkaloids.

Kam, Sim, Pang et al.· Bioorg Med Chem Lett· 2004· PMID: 15357977
Unclassified

A series of indole alkaloids of the ibogan-type was assessed for their cytotoxic effects as well as their potential in reversing MDR in vincristine-resistant KB cells. Of a total of 25 compounds tested, 3(S)-cyanocoronaridine, 3(S)-cyanoisovoacangine, 3(S)-cyanovoacangine, and 10...

Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.

Pace, Glick, Maisonneuve et al.· Eur J Pharmacol· 2004· PMID: 15178360
Preclinical (Animal)

18-Methoxycoronaridine, a novel iboga alkaloid congener, reduces drug self-administration in animal models of addiction. Previously, we proposed that these effects are mediated by the ability of 18-methoxycoronaridine to inhibit nicotinic alpha3beta4 acetylcholine receptors. In a...

Biologically active ibogan and vallesamine derivatives from Tabernaemontana divaricata.

Kam, Pang, Choo et al.· Chem Biodivers· 2004· PMID: 17191876
Unclassified

Six new indole alkaloids, viz., (3S)-3-cyanocoronaridine (2), (3S)-3-cyanoisovoacangine (3), conolobine A (5), conolobine B (6), conolidine (7), and (3R/3S)-3-ethoxyvoacangine (8), in addition to 36 known ones, were obtained from the stem-bark extract of the Malayan Tabernaemonta...

Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine.

Silva, Cirne-Santos, Frugulhetti et al.· Planta Med· 2004· PMID: 15386189
Unclassified

The Iboga alkaloid congener 18-methoxycoronaridine (18-MC) exhibits in vitro leishmanicidal and in vivo anti-addiction properties. In this paper, we describe that 18-MC inhibits HIV-1 infection in human peripheral blood mononuclear cells (PBMCs) and monocyte-derived macrophages. ...

Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine.

O'Hearn, Molliver· Neuroscience· 2004· PMID: 15262328
Preclinical (Animal)

Ibogaine is a tremorigenic hallucinogen that has been proposed for clinical use in treating addiction. We previously reported that ibogaine, administered systemically, produces degeneration of a subset of Purkinje cells in the cerebellum, primarily within the vermis. Ablation of ...

Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.

Levant, Pazdernik· Brain Res· 2004· PMID: 15019575
Preclinical (Animal)

Ibogaine, a hallucinogenic indole alkaloid, has been proposed as a treatment for addiction to opioids and other drugs of abuse. The mechanism for its putative anti-addictive effects is unknown. In this study, the effects of ibogaine on local cerebral glucose utilization (LCGU) we...

Combating substance abuse with ibogaine: pre- and posttreatment recommendations and an example of successive model fitting analyses.

Hittner, Quello· J Psychoactive Drugs· 2004· PMID: 15369200
Review

Ibogaine is an indole alkaloid derived from the root bark of the African shrub Tabernan the iboga and it has been used for many years as a medicinal and ceremonial agent in West Central Africa. Furthermore, both anecdotal observations and recent studies suggest that ibogaine alle...

[Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].

Kazlauskas, Kontrimaviciūte, Sveikata· Medicina (Kaunas)· 2004· PMID: 15064541
Review

The review of scientific literature, concerning the indol alkaloid Ibogaine, which is extracted from the bush Tabernanthe Iboga, is presented in this article. Used as a stimulating factor for hundred of years in non-traditional medicine, this alkaloid could be important for moder...

Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.

Wiley, Harvey, Balster et al.· Psychopharmacology (Berl)· 2003· PMID: 12459931
Preclinical (Animal)

Phencyclidine (PCP) binds with high affinity to a site located within the ionophore of N-methyl- D-aspartate (NMDA) receptors. Previous studies have demonstrated that PCP and other high-affinity NMDA channel blockers reliably disrupt prepulse inhibition (PPI) of acoustic startle,...

Doubts cast on antimalarial drug.

Orellana· Lancet Infect Dis· 2003· PMID: 12560176
Unclassified

Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells.

Meschini, Marra, Calcabrini et al.· Int J Oncol· 2003· PMID: 14612920
Unclassified

Multidrug-resistance (MDR) is largely caused by the efflux of therapeutics from the tumor cell by means of P-glycoprotein (P-gp), resulting in reduced efficacy of the chemotherapy. In order to overcome MDR, substances, such as verapamil and cyclosporin A (CsA), were employed. As ...

Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.

Maisonneuve, Glick· Pharmacol Biochem Behav· 2003· PMID: 12895678
Preclinical (Animal)

18-Methoxycoronaridine (18-MC), a novel iboga alkaloid congener that decreases drug self-administration in several animal models, may be a potential treatment for multiple forms of drug abuse. In animal models, 18-MC reduced intravenous morphine, cocaine, methamphetamine and nico...

Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents.

Kuehne, He, Jokiel et al.· J Med Chem· 2003· PMID: 12801235
Preclinical (Animal)

Variation of the methoxycarbonyl and C-18 substituents of the antiaddictive compound 18-methoxycoronaridine, and contraction of its isoquinuclidine ring segment, provided 15 congeners for SAR evaluation at opioid and alpha3beta4 nicotinic acetylcholine receptors. The opioid activ...

Plant derivatives in the treatment of alcohol dependency.

Rezvani, Overstreet, Perfumi et al.· Pharmacol Biochem Behav· 2003· PMID: 12895677
Review

The present review summarizes the findings of the effects of extracts of purified compounds from several plants on alcohol intake in alcohol-preferring rats. These include St. John's wort (Hypericum perforatum, HPE), kudzu (Pueraria lobata) and ibogaine (Tabernanthe iboga). Alcoh...

Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes.

Passarella, Favia, Giardini et al.· Bioorg Med Chem· 2003· PMID: 12614886
Preclinical (Lab)

Synthesis of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes by cycloaddition and subsequent cross-coupling reaction is described. Binding affinity of these novel compounds towards the characteristic receptorial targets of ibogaine is illustrated....

Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.

Leal, Michelin, Souza et al.· Prog Neuropsychopharmacol Biol Psychiatry· 2003· PMID: 12921910
Preclinical (Animal)

Ibogaine (IBO) is an alkaloid with putative antiaddictive properties, alleviating opiates dependence and withdrawal. The glutamate N-methyl-D-aspartate (NMDA) receptors have been implicated in the physiological basis of drug addiction; accordingly, IBO acts as a noncompetitive NM...

Hallucinogens and redemption.

de Rios, Grob, Baker· J Psychoactive Drugs· 2002· PMID: 12422934
Unclassified

This article examines drug substitution with regard to hallucinogens (ayahuasca, ibogaine, peyote and LSD) set within the concept of redemption. The model examines both religious and secular approaches to the contemporary use of hallucinogens in drug substitution, both by scienti...

Why do Purkinje cells die so easily after global brain ischemia? Aldolase C, EAAT4, and the cerebellar contribution to posthypoxic myoclonus.

Welsh, Yuen, Placantonakis et al.· Adv Neurol· 2002· PMID: 11968459
Preclinical (Animal)

The experiments strongly suggested that the reason why Purkinje cells die so easily after global brain ischemia relates to deficiencies in aldolase C and EAAT4 that allow them to survive pathologically intense synaptic input from the inferior olive after the restoration of blood ...

Treatment of allergic rhinitis: H1-antihistamines and intranasal steroids.

Wang· Curr Drug Targets Inflamm Allergy· 2002· PMID: 14561186
Review

Allergic rhinitis is charterized as an inflammatory disease of the nasal mucosa. In clinical practice, H(1)-antihistamines and topical corticosteroids are most commonly used pharmacological agents for the treatment of allergic rhinitis. The beneficial effects of steroids depend u...

Liquid chromatographic/mass spectrometric determination of biologically active alkaloids in extracts of Peschiera fuschiaefolia.

Lépine, Milot, Zamir et al.· J Mass Spectrom· 2002· PMID: 11857766
Preclinical (Lab)

Four alkaloids were isolated from an alcoholic extract of the bark from the stem of Peschiera fuschiaefolia. Two of these compounds, voacamine and voacamidine, are dimeric alkaloids which are thought to be responsible for the antimalarial activity of these extracts. The mass spec...

In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis.

Delorenzi, Freire-de-Lima, Gattass et al.· Antimicrob Agents Chemother· 2002· PMID: 12069962
Preclinical (Animal)

In previous studies, we demonstrated the leishmanicide effect of coronaridine, a natural indole alkaloid isolated from stem bark of Peschiera australis (Delorenzi et al., Antimicrob. Agents Chemother. 45:1349-1354, 2001). In this study we show the leishmanicidal effect of the syn...

Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons.

Zhang, Cuevas· J Neurophysiol· 2002· PMID: 12037190
Preclinical (Animal)

Studies on the expression and cellular function of sigma receptors in autonomic neurons were conducted in neonatal rat intracardiac and superior cervical (SCG) ganglia. Individual neurons from SCG and intracardiac ganglia were shown to express transcripts encoding the sigma-1 rec...

Addiction treatment strives for legitimacy.

Vastag· JAMA· 2002· PMID: 12495380
Preclinical (Animal)

Extraction studies of Tabernanthe iboga and Voacanga africana.

Jenks· Nat Prod Lett· 2002· PMID: 11942686
Preclinical (Lab)

The root bark of Tabernanthe iboga contains ibogaine as its predominant alkaloid and has been an important source of it. Ibogaine is used experimentally to interrupt drug addiction and allow therapeutic intervention, but is currently unaffordable to doctors in less economically d...

Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.

MacInnes, Handley· Br J Pharmacol· 2002· PMID: 11877331
Preclinical (Animal)

1. The molecular nature and functions of the I(2) subtype of imidazoline binding sites are unknown but evidence suggests an association with monoamine oxidase (MAO). Rats can distinguish the selective imidazoline I(2)-site ligand 2-BFI from vehicle in drug discrimination, indicat...

Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19.

Zhang, Ramamoorthy, Tyndale et al.· Drug Metab Dispos· 2002· PMID: 12019193
Preclinical (Animal)

18-Methoxycoronaridine, a newly developed ibogaine analog, has been reported to decrease the self-administration of morphine, cocaine, ethanol, and nicotine. It has also been reported to attenuate naltrexone-precipitated signs of morphine withdrawal. In this study, three metaboli...

Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.

Parke, Burton, McDonald et al.· Prog Neuropsychopharmacol Biol Psychiatry· 2002· PMID: 11817506
Preclinical (Animal)

It has been reported that ibogaine interferes with somatic withdrawal reactions in rats chronically treated with morphine. The present experiments demonstrated that ibogaine also interferes with motivational withdrawal reactions and somatic withdrawal reactions in rats treated wi...

Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration.

Glick, Maisonneuve, Kitchen· European journal of pharmacology· 2002· PMID: 11906717
Preclinical (Animal)

The iboga alkaloid ibogaine and the novel iboga alkaloid congener 18-methoxycoronaridine are putative anti-addictive agents. Using patch-clamp methodology, the actions of ibogaine and 18-methoxycoronaridine at various neurotransmitter receptor ion-channel subtypes were determined...

A review of chemical agents in the pharmacotherapy of addiction.

Levi, Borne· Current medicinal chemistry· 2002· PMID: 12369879
Review

Chemical substance abuse has tormented mankind throughout history. A number of chemical approaches have been employed in an attempt to treat chemical addiction. Unfortunately, most of these have proven unsuccessful though several chemical entities have been shown to be moderately...

Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation.

Onaivi, Ali, Chirwa· Annals of the New York Academy of Sciences· 2002· PMID: 12105083
Review

The mapping of the human genetic code will enable us to identify potential gene products involved in human addictions and diseases that have hereditary components. Thus, large-scale, parallel gene-expression studies, made possible by advances in microarray technologies, have show...

Evaluation of neurodegeneration in scrapie-infected animals by selective methods that detect cellular degeneration.

Ye, Rountree, Scallet et al.· Brain Res· 2001· PMID: 11489267
Preclinical (Animal)

Scrapie is a fatal neurodegenerative disease of sheep and goats. The precise details of neuronal and neurite degeneration in scrapie-infected animals remain unknown. Using specific silver staining methods, we compared the neurodegeneration caused by treatment of rats with kainic ...

Antileishmanial activity of an indole alkaloid from Peschiera australis.

Delorenzi, Attias, Gattass et al.· Antimicrob Agents Chemother· 2001· PMID: 11302794
Preclinical (Animal)

In this study, we show the leishmanicidal effects of a chloroform fraction (CLF) and a purified indole alkaloid obtained from crude stem extract of Peschiera australis against Leishmania amazonensis, a causative agent of cutaneous leishmaniasis in the New World. In a bioassay-gui...

Fluoro-Jade and silver methods: application to the neuropathology of scrapie, a transmissible spongiform encephalopathy.

Ye, Carp, Schmued et al.· Brain Res Brain Res Protoc· 2001· PMID: 11673092
Preclinical (Animal)

Traditional methods for evaluating neurodegeneration include variations of Nauta's selective silver-staining techniques. The Fluoro-Jade (FJ) method applies a novel fluorescent, anionic stain for localizing degenerating neurons. FJ has produced comparable results to the silver me...

Biological activities of the plant-derived bisindole voacamine with reference to malaria.

Ramanitrahasimbola, Rasoanaivo, Ratsimamanga-Urverg et al.· Phytother Res· 2001· PMID: 11180519
Preclinical (Animal)

The in vivo antiplasmodial activity of voacamine was assessed in a 4-day test. It was shown to exhibit in vivo activity with 25.4% and 43.4% inhibition of parasitaemia with 2.5 and 10 mg/kg, respectively. In synchronized cultures, it was found to act on trophozoite and schizont s...

← PrevPage 9 / 14Next →